SE8502317L - Cefalosporinantibiotika - Google Patents

Cefalosporinantibiotika

Info

Publication number
SE8502317L
SE8502317L SE8502317A SE8502317A SE8502317L SE 8502317 L SE8502317 L SE 8502317L SE 8502317 A SE8502317 A SE 8502317A SE 8502317 A SE8502317 A SE 8502317A SE 8502317 L SE8502317 L SE 8502317L
Authority
SE
Sweden
Prior art keywords
group
compounds
hydrogen
carboxyl
optionally substituted
Prior art date
Application number
SE8502317A
Other languages
English (en)
Swedish (sv)
Other versions
SE8502317D0 (sv
Inventor
R Bell
P D Hallam
M W Foxton
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8502317D0 publication Critical patent/SE8502317D0/xx
Publication of SE8502317L publication Critical patent/SE8502317L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/187-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8502317A 1984-05-10 1985-05-09 Cefalosporinantibiotika SE8502317L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848411954A GB8411954D0 (en) 1984-05-10 1984-05-10 Cephalosporin antibiotics

Publications (2)

Publication Number Publication Date
SE8502317D0 SE8502317D0 (sv) 1985-05-09
SE8502317L true SE8502317L (sv) 1985-11-11

Family

ID=10560740

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8502317A SE8502317L (sv) 1984-05-10 1985-05-09 Cefalosporinantibiotika

Country Status (18)

Country Link
US (1) US4666899A (no)
JP (1) JPS6156185A (no)
KR (1) KR850008345A (no)
AT (1) AT391319B (no)
AU (1) AU594923B2 (no)
BE (1) BE902381A (no)
CH (1) CH671765A5 (no)
DE (1) DE3516777A1 (no)
DK (1) DK205085A (no)
ES (1) ES8702917A1 (no)
FR (1) FR2564095B1 (no)
GB (2) GB8411954D0 (no)
IT (1) IT1181667B (no)
LU (1) LU86153A1 (no)
NL (1) NL8501324A (no)
NZ (1) NZ212029A (no)
SE (1) SE8502317L (no)
ZA (1) ZA853518B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
US4799708A (en) * 1986-10-27 1989-01-24 Honda Giken Kogyo Kabushiki Kaisha Off-road vehicle
JPH02124724A (ja) * 1988-11-02 1990-05-14 Taiyo Yuden Co Ltd Mn−Zn系フェライト材料
US6248881B1 (en) 1991-03-08 2001-06-19 Biochemie Gmbh Intermediates and process for the production of 3-vinyl cephalosporins
GB0019124D0 (en) 2000-08-03 2000-09-27 Pfizer Novel process

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1342241A (en) * 1970-01-23 1974-01-03 Glaxo Lab Ltd Cephalosporin compounds
US4107431A (en) * 1970-01-23 1978-08-15 Glaxo Laboratories Limited Δ3 -3-Vinyl or substituted vinyl-4-carboxy cephalosporins
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US4609730A (en) * 1982-11-22 1986-09-02 Fujisawa Pharmaceutical Co., Ltd. 7-[substituted imino-2-(2-aminothiazol-4-yl)-acetamido]-3(2,2-dihalovinyl or ethynyl)-3-cephem-4-carboxylic acid (syn isomers), having antimicrobial activities
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives
DE3306102C1 (de) * 1983-02-22 1984-08-02 Ludwig Heumann & Co GmbH, 8500 Nürnberg Pyridin-Pyrimidinon-Derivate,Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
NL8501324A (nl) 1985-12-02
BE902381A (fr) 1985-11-12
GB8411954D0 (en) 1984-06-13
CH671765A5 (no) 1989-09-29
DE3516777A1 (de) 1985-11-14
NZ212029A (en) 1988-09-29
AU594923B2 (en) 1990-03-22
ES542958A0 (es) 1987-01-16
ES8702917A1 (es) 1987-01-16
IT8548062A1 (it) 1986-11-09
AT391319B (de) 1990-09-25
ZA853518B (en) 1987-01-28
DK205085A (da) 1985-11-11
DK205085D0 (da) 1985-05-09
ATA139685A (de) 1990-03-15
GB2159515A (en) 1985-12-04
FR2564095B1 (fr) 1988-10-14
LU86153A1 (fr) 1986-03-24
FR2564095A1 (fr) 1985-11-15
IT8548062A0 (it) 1985-05-09
KR850008345A (ko) 1985-12-16
US4666899A (en) 1987-05-19
JPS6156185A (ja) 1986-03-20
SE8502317D0 (sv) 1985-05-09
GB2159515B (en) 1987-12-23
AU4221185A (en) 1985-11-14
GB8511703D0 (en) 1985-06-19
IT1181667B (it) 1987-09-30

Similar Documents

Publication Publication Date Title
IL73893A (en) 11-aryl-13-estradiene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
FI823923A0 (fi) Antifibrinolytiskt aktiva foereningar
NZ308518A (en) Antibacterial cephalosporins
NZ218243A (en) B-carboline derivatives and pharmaceutical compositions
KR930016402A (ko) 항-hiv 활성을 갖는 이미다졸 유도체
SE8502317D0 (sv) Cefalosporinantibiotika
ES8304062A1 (es) "procedimiento de preparacion de nuevos derivados 4-aminoetoxi-5-isopropil-2-metil".
IL75239A (en) Derivatives of 7-(1-(2-aminothiazol-4-yl)-ethen-carboxamido)-4-carboxy-3-cephemmethylaminium inner salt,their preparation,pharmaceutical compositions containing them and their use as growth-promoters in livestock rearing or as antioxidants
CA2089368A1 (en) Antibacterial penem esters derivatives
KR950704333A (ko) 신규한 세펨 유도체(novel cephem derivatives)
GR3015216T3 (en) (meth)acrylic compounds containing the thiocyanate group, process for their preparation and their use in the preparation of new polymers.
NZ208996A (en) 5-substituted(1,2,4 triazpyrimidin-2-amine derivatives and pharmaceutical compositions
ATE42571T1 (de) Antibiotikum a 51568, faktoren a und b.
ES2064440T3 (es) Cefalosporinas, proceso para su preparacion, intermedios y composiciones farmaceuticas.
GB2017103A (en) Cephalosporin analogues
ES8401081A1 (es) Procedimiento para la obtencion de compuestos del acido 7b-aminotriazolilacetilamino-3-cefem-4-carboxilico.
GR72800B (no)
EP0177897A3 (en) Antibacterial 7beta-heterocyclic-cephem
DE3173404D1 (en) Biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
ATE79882T1 (de) Antibakterielle verbindungen.
JPS5278891A (en) Synthesis of cephalosporin antibiotics

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8502317-4

Effective date: 19900309

Format of ref document f/p: F